StockWatch
·
Pharmaceuticals
Management Change29 May 2026, 01:04 am

538634 Appoints Ravi Jain as Independent Director

AI Summary

The Board of Directors of 538634, in a meeting held on May 28, 2026, approved the appointment of Mr. Ravi Jain as an Additional Director, categorized as a Non-Executive Independent Director. The appointment is effective from May 28, 2026, for a term of 5 years, subject to the approval of shareholders at the upcoming general meeting. Mr. Jain brings over 10 years of experience in marketing and business development, with expertise in strategic planning, risk assessment, and governance. The company affirmed that Mr. Jain is not debarred from holding a directorship by SEBI or any other authority and is not related to any other director on the board.

Key Highlights

  • Board appointed Mr. Ravi Jain as an Additional Independent Director.
  • Appointment is for a 5-year term, effective May 28, 2026.
  • Mr. Jain brings over 10 years of marketing and business development experience.
  • His appointment is subject to shareholder approval.
  • He is not related to existing directors and not debarred by SEBI.